The Targeting Phage Therapy 2023 Best Short Oral Presentation award was discerned to:
Bacteriophage-Antibiotic Combination Therapy Against Extensively Drug-Resistant Pseudomonas Aeruginosa Infection to Allow Liver Transplantation in a Toddler
Brieuc Van Nieuwenhuyse, UC Louvain
Dr. Van Nieuwenhuyse explained to Targeting Phage Therapy: “My research focuses on bidirectional translational research, trying to analyze specific mechanisms that have likely modulated phage therapy’s outcomes in former treated patients, and in turn trying to apply the conclusions of this research to the treatment protocol of future phage therapy patients. Current and future projects focus on exploring, inter alia, the clinical relevance of phage-antibiotic interactions, of phage immune neutralization, of bacterial phage resistance dynamics and induced phage co-evolution, and also on the contribution of specific phage features to their lytic power in mucus-rich environments.”
You can learn about this inspiring finding and talk in Targeting Phage Therapy 2023 Replay and Abstracts Book.
Targeting Phage Therapy 2023 Congress
6th World Conference
June 1-2, 2023 – Paris, France
Iddo Nadav Weiner, VP of Research at BiomX, Israel presented a short oral talk entitled “A Phase 1b/2a Randomized, Double-blind, Placebo-controlled Study Evaluating Nebulized Phage Therapy in Cystic Fibrosis Subjects With Chronic Pseudomonas Aeruginosa Pulmonary Infection ” during Targeting Phage Therapy 2023 on June 1-2 in Paris.
Adam Ostrowski, Cellexus, United Kingdom presented a short oral talk entitled “Implementing GMP Manufacturing for Phage Therapy” during Targeting Phage Therapy 2023 on June 1-2 in Paris.
